Last quarter (Q4 2023), TG Therapeutics's total revenue was $43.97M, an increase of 54183.95% from the same quarter last year. In Q4, TG Therapeutics's net income was $-54.92M. See TG Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 233.62M	$ 233.66M	$ 2.79M	$ 6.69M	$ 152.00K	$ 152.00K
Cost of Revenue	$ 14.99M	$ 14.13M	-	$ 790.00K	$ 0.00	-
Gross Profit	$ 218.67M	$ 219.53M	$ 2.79M	$ 5.90M	$ 152.00K	-
Operating Expense	$ 122.17M	$ 123.03M	$ 195.62M	$ 350.67M	$ 273.75M	$ 169.21M
Operating Income	$ 35.09M	$ 20.63M	$ -192.84M	$ -344.77M	$ -273.59M	$ -169.06M
Net Non Operating Interest Income Expense	$ -12.62M	$ -12.62M	$ -10.19M	$ -5.64M	$ -6.33M	$ -5.29M
Other Income Expense	$ -5.04M	$ -5.04M	$ -4.70M	$ -2.31M	$ 542.00K	$ 1.47M
Pretax Income	$ 5.38M	$ 13.06M	$ -178.88M	$ -348.10M	$ -279.38M	$ -172.87M
Tax Provision	$ 390.00K	$ 390.00K	$ -41.65M	$ -428.00K	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -9.46M	$ 12.67M	$ -178.88M	$ -348.10M	$ -279.38M	$ -172.87M
Basic EPS	$ 0.08	$ 0.09	$ -1.46	$ -2.63	$ -2.42	$ -1.96
Diluted EPS	$ 0.02	$ 0.09	$ -1.46	$ -2.63	$ -2.42	$ -1.96
Basic Average Shares	$ 567.82M	$ 141.96M	$ 135.41M	$ 132.22M	$ 115.33M	$ 88.37M
Diluted Average Shares	$ 594.03M	$ 148.51M	$ 135.41M	$ 132.22M	$ 115.33M	$ 88.37M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 137.16M	$ 137.16M	$ 195.62M	$ 351.46M	$ 273.75M	$ 169.21M
Net Income From Continuing And Discontinued Operation	$ 12.67M	$ 12.67M	$ -198.34M	$ -348.10M	$ -279.38M	$ -172.87M
Normalized Income	$ 35.24M	$ 10.32M	$ -220.53M	-	$ -279.38M	$ -172.87M
Interest Expense	-	-	-	-	$ 6.33M	$ 5.29M
EBIT	$ 18.00M	$ 25.68M	$ -174.14M	$ -345.93M	$ -273.05M	$ -167.58M
EBITDA	$ 22.76M	$ 30.44M	$ -172.11M	$ -343.84M	$ -272.89M	$ -167.48M

Currency in USD

TG Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing